Pacific Edge rises as wider sharemarket stutters
Pacific Edge made a rapid recovery, rising more than 110% after receiving a reprieve on funding for its Cxbladder tests in the United States, while an uncertain New Zealand sharemarket had its first fall in eight trading days.